Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonviral skin gene therapy.

J C Vogel1

  • 1Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. jonvogel@box-j-nih.gov

Human Gene Therapy
|November 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographical and environmental distribution of C<sub>3</sub> and C<sub>4</sub> grasses in the Sinai, Negev, and Judean deserts.

Oecologia·2017
Same author

Sporophytic self-incompatibility genes and mating system variation in Arabis alpina.

Annals of botany·2011
Same author

Population structure and historical biogeography of European Arabidopsis lyrata.

Heredity·2010
Same author

Genetic diversity and phylogeography in two diploid ferns, Asplenium fontanum subsp. fontanum and A. petrarchae subsp. bivalens, in the western Mediterranean.

Molecular ecology·2009
Same author

Genetic discontinuity, breeding-system change and population history of Arabis alpina in the Italian Peninsula and adjacent Alps.

Molecular ecology·2008
Same author

Recombination diversifies chloroplast trnF pseudogenes in Arabidopsis lyrata.

Journal of evolutionary biology·2007

Nonviral skin gene therapy effectively delivers genes for applications like genetic immunization and tumor regression. Delivery methods influence immune responses, with DNA acting as an adjuvant to activate skin cells and induce IL-12 expression.

Area of Science:

  • Dermatology
  • Immunology
  • Gene Therapy

Background:

  • Nonviral gene therapy offers a direct route for gene delivery and transient expression in skin.
  • Various nonviral methods exist, each with distinct efficiencies and efficacies for therapeutic goals.

Purpose of the Study:

  • To analyze the efficiency and efficacy of different nonviral delivery methods for skin gene therapy.
  • To explore the role of DNA as an immunostimulatory adjuvant in genetic immunization.
  • To discuss the potential for future applications in treating skin diseases.

Main Methods:

  • Review and analysis of existing nonviral skin gene therapy delivery methods.
  • Examination of immune response modulation (Th1/Th2) based on delivery system choice.
  • Investigation of mechanisms involving skin dendritic cell activation and IL-12 induction.

Related Experiment Videos

Main Results:

  • Delivery method choice impacts the type of immune response (Th1 vs. Th2) in genetic immunization.
  • DNA acts as an immunostimulatory adjuvant, crucial for activating skin dendritic cells and inducing IL-12.
  • Nonviral skin gene therapy demonstrates efficacy in enhancing tumor regression in animal models via immune response induction.

Conclusions:

  • Nonviral skin gene therapy is a viable approach for genetic immunization and enhancing anti-tumor immunity.
  • Understanding delivery method-specific immune responses and DNA's adjuvant role is key for optimizing genetic immunization.
  • Future advancements require targeted gene delivery to specific skin cells and prolonged gene expression for broader therapeutic use.